查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1631164

外用藥物市場規模、佔有率、趨勢分析報告：依給藥途徑、類型、最終用途、地區、細分預測，2025-2030 年

Topical Drugs Market Size, Share & Trends Analysis Report By Route Of Administration (Dermal, Ophthalmic, Rectal, Vaginal, Nasal), By Type (Semi-solid, Transdermal), By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

外用藥物市場的成長與趨勢

根據 Grand View Research Inc. 的一份新報告，到 2030 年全球外用藥物市場規模預計將達到 2,693 億美元。

預計 2025 年至 2030 年間，該產業的複合年成長率為 6.0%。推動該產業成長的關鍵因素包括皮膚病發病率的上升以及主要企業之間的策略聯盟。預計預測期內，乾癬、異位性皮膚炎和濕疹等皮膚感染疾病盛行率不斷上升，加上對眼耳治療的需求不斷成長，將推動對經皮或經皮藥物的需求。例如，2021年10月，艾伯維公司（AbbVie Inc.）獲得FDA核准，推出用於治療老花眼的鹽酸毛果芸香鹼滴眼液Vuity。

此外，根據 NCBI 的數據，乾癬在歐洲的盛行率約為 1.92%，在北美的盛行率約為 1.5%。治療皮膚病的外用藥物的推出預計也將推動皮膚病藥物的需求。例如，2020年9月，加拿大博士倫醫療公司針對乾癬患者推出了一種新型抗乾癬藥物DuoBry Lotion。預計技術進步以及愛爾康公司和諾華公司等主要企業之間活性化的併購活動將推動該行業成長。例如，2022年6月，諾華公司收購了Kedalion Therapeutics，從而獲得了AcuStream技術，該技術有助於實現眼科藥物的精準經皮給藥。

此外，2022 年 5 月，Alcon Inc. 從 Kala Pharmaceuticals, Inc. 收購了局部眼科藥物 Eysuvis（洛替潑諾依碳酸酯混懸液），將其添加到其現有的乾眼症治療產品組合中。例如，根據世界衛生組織的數據，全球每年約有 1,100 萬人發生燒傷，其中約 18 萬人死亡。多種外用藥物可用於治療燒燙傷，包括磺胺嘧啶銀霜、鉍浸漬凡士林紗布、硝酸鈰、醋酸磺胺米隆和結晶銀。

外用藥物市場報告重點

  • 藥物輸送將佔據市場主導地位，到 2024 年將佔 54.1% 的佔有率。
  • 半固態劑型憑藉其多功能性、易用性以及將活性成分直接輸送到皮膚的有效性，在 2024 年佔據了 61.9% 的收入佔有率，佔據了市場主導地位。
  • 2024 年醫院和診所的收入佔有率最大，為 38.9%。這是因為需要專門干預的皮膚病和慢性病的發生率不斷上升。
  • 2024 年，北美外用藥物市場在全球市場佔據主導地位，這得益於皮膚病的高發性、先進的醫療基礎設施以及強勁的研發投入。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章 外用藥物市場變數、趨勢與範圍

  • 市場體系展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 商業環境分析
    • 產業分析 – 波特五力分析
    • PESTLE分析

第 4 章外用藥物市場：給藥途徑業務分析

  • 2024 年和 2030 年市場佔有率
  • 給藥途徑細分儀表板
  • 2018 年至 2030 年按給藥途徑分類的市場規模、預測和趨勢分析
  • 經經皮給藥
  • 眼科藥物輸送
  • 直腸給藥
  • 陰道給藥
  • 鼻腔內給藥

第 5 章局部用藥市場：類型業務分析

  • 2024 年及 2030 年各類型市場佔有率
  • 類型細分儀表板
  • 2018 年至 2030 年按類型分類的市場規模、預測與趨勢分析
  • 半固態製劑
  • 液體製劑
  • 固態製劑
  • 經皮產品

第6章外用藥物市場：最終用途業務分析

  • 2024 年及 2030 年終端用途市場佔有率
  • 最終用途細分儀表板
  • 2018 年至 2030 年按最終用途分類的市場規模、預測和趨勢分析
  • 居家醫療
  • 醫院和診所
  • 燒燙傷中心
  • 其他設施

第 7 章：外用藥物市場：區域、估計與趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 2018-2030 年市場規模及預測趨勢分析
  • 北美洲
    • 按國家/地區，2018 年至 2030 年
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 按國家/地區，2018 年至 2030 年
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 丹麥
    • 瑞典
  • 亞太地區
    • 按國家/地區，2018 年至 2030 年
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 按國家/地區，2018 年至 2030 年
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 按國家/地區，2018 年至 2030 年
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 參與者概述
  • 企業市場分析
  • 公司分類
  • 戰略地圖
  • 公司簡介/上市公司
    • Bayer AG
    • Cipla
    • GSK plc
    • Johnson & Johnson Services, Inc.
    • Novartis AG
    • Bausch Health Companies Inc.
    • Hisamitsu Pharmaceuticals Co., Inc.
    • Merck KGaA
    • GLENMARK PHARMACEUTICALS LTD.
    • MedPharm Ltd.
Product Code: GVR-4-68039-959-4

Topical Drugs Market Growth & Trends:

The global topical drugs market size is expected to reach USD 269.3 billion by 2030, according to a new report by Grand View Research Inc. The industry is expected to grow at a CAGR of 6.0% from 2025 to 2030. The key factors contributing to the industry growth include the increased prevalence of skin disorders coupled with strategic collaborations between key players. The increasing prevalence of skin infections, such as psoriasis, atopic dermatitis, and eczema, coupled with the rising demand for eye and ear therapies is expected to drive the demand for transdermal or dermal medicines during the forecast period. For instance, in October 2021, AbbVie Inc. received FDA approval for Vuity, a pilocarpine HCl ophthalmic solution for treating presbyopia.

In addition, according to the NCBI, the prevalence of psoriasis is nearly 1.92% and 1.5% among European and North American populations. The launch of topical medicines to treat skin diseases is also anticipated to propel the demand for dermal drugs. For instance, in September 2020, Bausch Health, Canada launched a novel antipsoriatic agent, Duobrii lotion for psoriasis patients.Advancements in technology and increased acquisitions and mergers activities among key players, such as Alcon, Inc. and Novartis AG, are anticipated to boost the industry's growth. For instance, in June 2022, Novartis AG acquired Kedalion Therapeutics, thereby acquiring AcuStream technology to facilitate accurate dermal delivery of ophthalmic medicines.

Moreover, in May 2022, Alcon Inc. acquired Eysuvis (loteprednol etabonate suspension) for topical ophthalmic use from Kala Pharmaceuticals, Inc., thereby adding to its existing portfolio of dry eye drugs.A high incidence of burn injuries is expected to render high utilization of topical medicines in treating burn injuries. For instance, according to the WHO, an estimated 11 million burn injuries occur annually worldwide, out of which about 180,000 cases are fatal. Various topical agents are used in treating burn injuries including silver sulfadiazine cream, bismuth-impregnated petroleum gauze, cerium nitrate, mafenide acetate, and nanocrystalline silver among others.

Topical Drugs Market Report Highlights:

  • Dermal drug delivery dominated the market and accounted for a share of 54.1% in 2024, fueled by its capacity to offer targeted treatment, user-friendly application, and improved patient compliance.
  • Semi-solid formulations led the market with a revenue share of 61.9% in 2024 due to their versatility, ease of use, and effectiveness in delivering active ingredients directly to the skin.
  • Hospitals & clinics held the largest revenue share of 38.9% in 2024, driven by the growing prevalence of skin disorders and chronic diseases necessitating professional intervention.
  • North America topical drugs market dominated the global market in 2024, driven by a high prevalence of skin disorders, advanced healthcare infrastructure, and robust investments in research and development.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Route of Administration
    • 1.2.2. Type
    • 1.2.3. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Topical Drugs Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Topical Drugs Market: Route of Administration Business Analysis

  • 4.1. Route of Administration Market Share, 2024 & 2030
  • 4.2. Route of Administration Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million)
  • 4.4. Dermal Drug Delivery
    • 4.4.1. Dermal Drug Delivery Market, 2018 - 2030 (USD Million)
  • 4.5. Ophthalmic Drug Delivery
    • 4.5.1. Ophthalmic Drug Delivery Market, 2018 - 2030 (USD Million)
  • 4.6. Rectal Drug Delivery
    • 4.6.1. Rectal Drug Delivery Market, 2018 - 2030 (USD Million)
  • 4.7. Vaginal Drug Delivery
    • 4.7.1. Vaginal Drug Delivery Market, 2018 - 2030 (USD Million)
  • 4.8. Nasal Drug Delivery
    • 4.8.1. Nasal Drug Delivery Market, 2018 - 2030 (USD Million)

Chapter 5. Topical Drugs Market: Type Business Analysis

  • 5.1. Type Market Share, 2024 & 2030
  • 5.2. Type Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 5.4. Semi-solid Formulations
    • 5.4.1. Semi-solid Formulations Market, 2018 - 2030 (USD Million)
    • 5.4.2. Creams
      • 5.4.2.1. Creams Market, 2018 - 2030 (USD Million)
    • 5.4.3. Ointments
      • 5.4.3.1. Ointments Market, 2018 - 2030 (USD Million)
    • 5.4.4. Lotions
      • 5.4.4.1. Lotions Market, 2018 - 2030 (USD Million)
    • 5.4.5. Gel
      • 5.4.5.1. Gel Market, 2018 - 2030 (USD Million)
    • 5.4.6. Pastes
      • 5.4.6.1. Pastes Market, 2018 - 2030 (USD Million)
  • 5.5. Liquid Formulations
    • 5.5.1. Liquid Formulations Market, 2018 - 2030 (USD Million)
    • 5.5.2. Suspensions
      • 5.5.2.1. Suspensions Market, 2018 - 2030 (USD Million)
    • 5.5.3. Solutions
      • 5.5.3.1. Solutions Market, 2018 - 2030 (USD Million)
  • 5.6. Solid Formulations
    • 5.6.1. Solid Formulations Market, 2018 - 2030 (USD Million)
    • 5.6.2. Powders
      • 5.6.2.1. Powders Market, 2018 - 2030 (USD Million)
    • 5.6.3. Suppositories
      • 5.6.3.1. Suppositories Market, 2018 - 2030 (USD Million)
  • 5.7. Transdermal Products
    • 5.7.1. Transdermal Products Market, 2018 - 2030 (USD Million)
    • 5.7.2. Transdermal Patches
      • 5.7.2.1. Transdermal Patches Market, 2018 - 2030 (USD Million)
    • 5.7.3. Transdermal Semi-Solids
      • 5.7.3.1. Transdermal Semi-Solids Market, 2018 - 2030 (USD Million)

Chapter 6. Topical Drugs Market: End Use Business Analysis

  • 6.1. End Use Market Share, 2024 & 2030
  • 6.2. End Use Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Home Care Settings
    • 6.4.1. Home Care Settings Market, 2018 - 2030 (USD Million)
  • 6.5. Hospitals & Clinics
    • 6.5.1. Hospitals & Clinics Market, 2018 - 2030 (USD Million)
  • 6.6. Burn Centers
    • 6.6.1. Burn Centers Market, 2018 - 2030 (USD Million)
  • 6.7. Other Facilities
    • 6.7.1. Other Facilities Market, 2018 - 2030 (USD Million)

Chapter 7. Topical Drugs Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030
  • 7.4. North America
    • 7.4.1. North America Topical Drugs Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework
      • 7.4.2.3. Competitive Insights
      • 7.4.2.4. U.S. Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework
      • 7.4.3.3. Competitive Insights
      • 7.4.3.4. Canada Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Regulatory Framework
      • 7.4.4.3. Competitive Insights
      • 7.4.4.4. Mexico Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Topical Drugs Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework
      • 7.5.2.3. Competitive Insights
      • 7.5.2.4. UK Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework
      • 7.5.3.3. Competitive Insights
      • 7.5.3.4. Germany Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework
      • 7.5.4.3. Competitive Insights
      • 7.5.4.4. France Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework
      • 7.5.5.3. Competitive Insights
      • 7.5.5.4. Italy Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework
      • 7.5.6.3. Competitive Insights
      • 7.5.6.4. Spain Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Norway
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework
      • 7.5.7.3. Competitive Insights
      • 7.5.7.4. Norway Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework
      • 7.5.8.3. Competitive Insights
      • 7.5.8.4. Denmark Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Sweden
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Regulatory Framework
      • 7.5.9.3. Competitive Insights
      • 7.5.9.4. Sweden Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Topical Drugs Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework
      • 7.6.2.3. Competitive Insights
      • 7.6.2.4. Japan Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework
      • 7.6.3.3. Competitive Insights
      • 7.6.3.4. China Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework
      • 7.6.4.3. Competitive Insights
      • 7.6.4.4. India Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework
      • 7.6.5.3. Competitive Insights
      • 7.6.5.4. South Korea Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework
      • 7.6.6.3. Competitive Insights
      • 7.6.6.4. Australia Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory Framework
      • 7.6.7.3. Competitive Insights
      • 7.6.7.4. Thailand Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Topical Drugs Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework
      • 7.7.2.3. Competitive Insights
      • 7.7.2.4. Brazil Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework
      • 7.7.3.3. Competitive Insights
      • 7.7.3.4. Argentina Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA Topical Drugs Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework
      • 7.8.2.3. Competitive Insights
      • 7.8.2.4. South Africa Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework
      • 7.8.3.3. Competitive Insights
      • 7.8.3.4. Saudi Arabia Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework
      • 7.8.4.3. Competitive Insights
      • 7.8.4.4. UAE Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Framework
      • 7.8.5.3. Competitive Insights
      • 7.8.5.4. Kuwait Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Bayer AG
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Cipla
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. GSK plc
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Johnson & Johnson Services, Inc.
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Novartis AG
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Bausch Health Companies Inc.
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Hisamitsu Pharmaceuticals Co., Inc.
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Merck KGaA
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. GLENMARK PHARMACEUTICALS LTD.
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. MedPharm Ltd.
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global topical drugs market, by region, 2018 - 2030 (USD Million)
  • Table 4 Global topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 5 Global topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 6 Global topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 7 North America topical drugs market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 9 North America topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 10 North America topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 11 U.S. topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 12 U.S. topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 13 U.S. Topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 14 Canada topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 15 Canada topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 16 Canada topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 17 Mexico topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 18 Mexico topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 19 Mexico topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Europe topical drugs market, by country, 2018 - 2030 (USD Million)
  • Table 21 Europe topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 22 Europe topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 23 Europe topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 24 UK topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 25 UK topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 26 UK Topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 27 Germany topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 28 Germany topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 29 Germany topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 30 France topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 31 France topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 32 France Topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 33 Italy topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 34 Italy topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 35 Italy topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 36 Spain topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 37 Spain topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 38 Spain topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 39 Norway topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 40 Norway topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 41 Norway Topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 42 Denmark topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 43 Denmark topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 44 Denmark topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Sweden topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 46 Sweden topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 47 Sweden topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific topical drugs market, by country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Japan topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 53 Japan topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 54 Japan topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 55 China topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 56 China topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 57 China topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 58 India topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 59 India topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 60 India topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Australia topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 62 Australia topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 63 Australia topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 64 South Korea topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 65 South Korea topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 66 South Korea topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 67 Thailand topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 68 Thailand topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 69 Thailand topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 70 Latin America topical drugs market, by country, 2018 - 2030 (USD Million)
  • Table 71 Latin America topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 72 Latin America topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 73 Latin America topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 74 Brazil topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 75 Brazil topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 76 Brazil topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 77 Argentina topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 78 Argentina topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 79 Argentina topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Topical drugs market, by country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 84 South Africa topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 85 South Africa topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 86 South Africa topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 90 UAE topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 91 UAE topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 92 UAE topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 93 Kuwait topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 94 Kuwait topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 95 Kuwait topical drugs market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Topical drugs market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Route of administration and type outlook (USD Million)
  • Fig. 10 End use outlook (USD Million)
  • Fig. 11 Competitive landscape
  • Fig. 12 Topical drugs market dynamics
  • Fig. 13 Topical drugs market: Porter's five forces analysis
  • Fig. 14 Topical drugs market: PESTLE analysis
  • Fig. 15 Topical drugs market: Route of administration segment dashboard
  • Fig. 16 Topical drugs market: Route of administration market share analysis, 2024 & 2030
  • Fig. 17 Dermal drug delivery market, 2018 - 2030 (USD Million)
  • Fig. 18 Ophthalmic drug delivery market, 2018 - 2030 (USD Million)
  • Fig. 19 Rectal drug delivery market, 2018 - 2030 (USD Million)
  • Fig. 20 Vaginal drug delivery market, 2018 - 2030 (USD Million)
  • Fig. 21 Nasal drug delivery market, 2018 - 2030 (USD Million)
  • Fig. 22 Topical drugs market: Type segment dashboard
  • Fig. 23 Topical drugs market: Type market share analysis, 2024 & 2030
  • Fig. 24 Semi-solid formulations market, 2018 - 2030 (USD Million)
  • Fig. 25 Creams market, 2018 - 2030 (USD Million)
  • Fig. 26 Ointments market, 2018 - 2030 (USD Million)
  • Fig. 27 Lotions market, 2018 - 2030 (USD Million)
  • Fig. 28 Gel market, 2018 - 2030 (USD Million)
  • Fig. 29 Pastes market, 2018 - 2030 (USD Million)
  • Fig. 30 Liquid formulations market, 2018 - 2030 (USD Million)
  • Fig. 31 Suspensions market, 2018 - 2030 (USD Million)
  • Fig. 32 Solutions market, 2018 - 2030 (USD Million)
  • Fig. 33 Solid formulations market, 2018 - 2030 (USD Million)
  • Fig. 34 Powders market, 2018 - 2030 (USD Million)
  • Fig. 35 Suppositories market, 2018 - 2030 (USD Million)
  • Fig. 36 Transdermal products market, 2018 - 2030 (USD Million)
  • Fig. 37 Transdermal patches market, 2018 - 2030 (USD Million)
  • Fig. 38 Transdermal semi-solids market, 2018 - 2030 (USD Million)
  • Fig. 39 Topical drugs market: End use segment dashboard
  • Fig. 40 Topical drugs market: End use market share analysis, 2024 & 2030
  • Fig. 41 Home care settings market, 2018 - 2030 (USD Million)
  • Fig. 42 Hospitals & clinics market, 2018 - 2030 (USD Million)
  • Fig. 43 Burn centers market, 2018 - 2030 (USD Million)
  • Fig. 44 Other facilities market, 2018 - 2030 (USD Million)
  • Fig. 45 Topical drugs market revenue, by region
  • Fig. 46 Regional marketplace: Key takeaways
  • Fig. 47 Regional marketplace: Key takeaways
  • Fig. 48 North America topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 49 U.S. country dynamics
  • Fig. 50 U.S. topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 51 Canada country dynamics
  • Fig. 52 Canada topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 53 Mexico country dynamics
  • Fig. 54 Mexico topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 55 Europe topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 56 UK country dynamics
  • Fig. 57 UK topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 58 Germany country dynamics
  • Fig. 59 Germany topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 60 France country dynamics
  • Fig. 61 France topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 62 Italy country dynamics
  • Fig. 63 Italy topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 64 Spain country dynamics
  • Fig. 65 Spain topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 66 Norway country dynamics
  • Fig. 67 Norway topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 68 Sweden country dynamics
  • Fig. 69 Sweden topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 70 Denmark country dynamics
  • Fig. 71 Denmark topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 72 Asia Pacific topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 73 Japan country dynamics
  • Fig. 74 Japan topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 75 China country dynamics
  • Fig. 76 China topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 77 India country dynamics
  • Fig. 78 India topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 79 Australia country dynamics
  • Fig. 80 Australia topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 81 South Korea country dynamics
  • Fig. 82 South Korea topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 83 Thailand country dynamics
  • Fig. 84 Thailand topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 85 Latin America topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 86 Brazil country dynamics
  • Fig. 87 Brazil topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 88 Argentina country dynamics
  • Fig. 89 Argentina topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 90 MEA topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 91 South Africa country dynamics
  • Fig. 92 South Africa topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 93 Saudi Arabia country dynamics
  • Fig. 94 Saudi Arabia topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 95 UAE country dynamics
  • Fig. 96 UAE topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 97 Kuwait country dynamics
  • Fig. 98 Kuwait topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 99 Company categorization
  • Fig. 100 Company market position analysis
  • Fig. 101 Strategic framework